C-RAD
ISIN: SE0002016352 | Ticker: CRAD | LEI: 549300SPXLHF15W2CU25
Country: Sweden
Through detailed knowledge about the radiotherapy business and its customer requirements we offer products for positioning, monitoring, tumor localization and radiation therapy. In new advanced radiation therapy techniques, the radiation dose must be delivered to the tumor with extremely high precision and microsecond timing. Our positioning and scanning products assure just that.
Our customers are radiation treatment clinics and diagnostics departments in hospitals worldwide. The aim is to contribute to a higher level of quality and efficiency for the customer.
In June 2015, C-RAD also completed its acquisition of the Franco-Belgian Cyrpa group, which added their innovative laser solutions for patient positioning and virtual simulation to the C-RAD portfolio.
2003
Served areaWorldwide
HeadquartersSjukhusvägen 12K, 75309 Uppsala – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 270,523,000.00 | 306,707,000.00 | 339,174,000.00 |
| Noncurrent Assets | N/A | 54,684,000.00 | 42,624,000.00 | 32,049,000.00 |
| Property Plant And Equipment | N/A | N/A | 12,587,000.00 | 10,106,000.00 |
| Office Equipment | N/A | 3,178,000.00 | 3,314,000.00 | 3,110,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 15,056,000.00 | 15,844,000.00 | N/A |
| Copyrights Patents And Other Industrial Property Rights Service And Operating Rights | N/A | 974,000.00 | 119,000.00 | N/A |
| Other Intangible Assets | N/A | 1,836,000.00 | 989,000.00 | N/A |
| Other Noncurrent Financial Assets | N/A | 23,776,000.00 | 13,085,000.00 | 227,000.00 |
| Current Assets | N/A | 215,839,000.00 | 264,083,000.00 | 307,125,000.00 |
| Inventories | N/A | 25,702,000.00 | 17,222,000.00 | 40,009,000.00 |
| Current Trade Receivables | N/A | 60,497,000.00 | 96,662,000.00 | 105,845,000.00 |
| Other Current Receivables | N/A | 5,252,000.00 | 11,190,000.00 | 9,440,000.00 |
| Cash and cash equivalents | 29,485,000.00 | 108,045,000.00 | 122,420,000.00 | 121,896,000.00 |
| Equity And Liabilities | N/A | 270,523,000.00 | 306,707,000.00 | 339,174,000.00 |
| Equity | 83,334,000.00 | 199,789,000.00 | 231,090,000.00 | 242,543,000.00 |
| Issued Capital | N/A | 5,049,000.00 | 5,063,000.00 | 5,065,000.00 |
| Retained Earnings | N/A | -178,209,000.00 | -153,107,000.00 | -145,628,000.00 |
| Other Reserves | N/A | -3,313,000.00 | -1,321,000.00 | 1,649,000.00 |
| Additional Paidin Capital | N/A | 376,262,000.00 | 380,455,000.00 | 381,458,000.00 |
| Liabilities | N/A | 70,734,000.00 | 75,617,000.00 | 96,630,000.00 |
| Noncurrent Liabilities | N/A | 7,436,000.00 | 6,374,000.00 | 4,076,000.00 |
| Current Liabilities | N/A | 63,298,000.00 | 69,243,000.00 | 92,555,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 17,071,000.00 | 22,641,000.00 | 31,007,000.00 |
| Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | 31,824,000.00 | 39,865,000.00 |
| Other Current Financial Liabilities | N/A | 11,046,000.00 | 11,604,000.00 | N/A |
| Other Current Liabilities | N/A | N/A | 11,604,000.00 | 18,634,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 221,628,000.00 | 261,152,000.00 | 301,326,000.00 |
| Other Work Performed By Entity And Capitalised | 5,266,000.00 | 4,572,000.00 | 10,113,000.00 |
| Employee Benefits Expense | 64,849,000.00 | 71,698,000.00 | 103,344,000.00 |
| Depreciation And Amortisation Expense | 9,031,000.00 | 9,707,000.00 | 10,112,000.00 |
| Other Expense By Nature | 44,329,000.00 | 52,479,000.00 | 75,762,000.00 |
| Profit Loss From Operating Activities | 17,084,000.00 | 35,995,000.00 | 21,758,000.00 |
| Finance Income | 37,000.00 | 10,000.00 | 162,000.00 |
| Finance Costs | 741,000.00 | 266,000.00 | 434,000.00 |
| Profit Loss Before Tax | 16,380,000.00 | 35,739,000.00 | 21,486,000.00 |
| Income Tax Expense Continuing Operations | 2,016,000.00 | 10,637,000.00 | 14,006,000.00 |
| Profit (loss) | 14,365,000.00 | 25,102,000.00 | 7,479,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 14,365,000.00 | 25,102,000.00 | 7,479,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -10,750,000.00 | 8,481,000.00 | -22,778,000.00 |
| Adjustments For Decrease Increase In Other Operating Receivables | N/A | -17,222,000.00 | -42,349,000.00 | -20,779,000.00 |
| Adjustments For Increase Decrease In Other Operating Payables | N/A | 20,636,000.00 | 5,945,000.00 | 21,795,000.00 |
| Other Adjustments For Noncash Items | N/A | 9,319,000.00 | 10,098,000.00 | 9,863,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 619,000.00 | 2,000.00 | 320,000.00 |
| Interest Received Classified As Operating Activities | N/A | 0.00 | 1,000.00 | 151,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 18,447,000.00 | 18,168,000.00 | 9,690,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 1,517,000.00 | 1,226,000.00 | 1,109,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -6,783,000.00 | -5,798,000.00 | -11,222,000.00 |
| Proceeds From Issuing Shares | N/A | 110,433,000.00 | 3,770,000.00 | 697,000.00 |
| Proceeds From Issuing Other Equity Instruments | N/A | 468,000.00 | 454,000.00 | 307,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 34,699,000.00 | 0.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 2,512,000.00 | 3,162,000.00 | 3,389,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 68,006,000.00 | 1,045,000.00 | -2,384,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 79,671,000.00 | 13,414,000.00 | -3,917,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -1,111,000.00 | 961,000.00 | 3,393,000.00 |
| Cash and cash equivalents | 29,485,000.00 | 108,045,000.00 | 122,420,000.00 | 121,896,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 09.06.23 | Christoffer Herou | Other | Buy | SEK 57,760.00 |
| 08.06.23 | Cecilia de Leeuw | Other | Buy | SEK 214,400.00 |
| 08.06.23 | Christoffer Herou | Other | Buy | SEK 107,200.00 |
| 07.06.23 | Kristina Willgård | Other | Buy | SEK 59,300.00 |
| 14.03.23 | Cecilia de Leeuw | Other | Buy | SEK 78,750.00 |
| 10.03.23 | Jenny Rosberg | Other | Buy | SEK 256,000.00 |
| 22.02.23 | Cecilia de Leeuw | Other | Buy | SEK 226,512.00 |
| 22.02.23 | Cecilia de Leeuw | Other | Buy | SEK 37,860.75 |
| 02.06.22 | Johan Danielsson | Other | Buy | SEK 4,325.00 |
| 23.05.22 | Henrik Bergentoft | Other | Buy | SEK 93,060.00 |
SE0002016352
LEI549300SPXLHF15W2CU25
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.